{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T06:57:12Z","timestamp":1763535432140},"reference-count":25,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.3892\/mco.2017.1241","type":"journal-article","created":{"date-parts":[[2017,5,5]],"date-time":"2017-05-05T11:20:13Z","timestamp":1493983213000},"page":"833-838","source":"Crossref","is-referenced-by-count":8,"title":["Target volume dose and clinical outcome in radiotherapy for primary marginal zone lymphoma of the ocular adnexa"],"prefix":"10.3892","volume":"6","author":[{"given":"Natuhiko","family":"Shirota","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetsugu","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachica","family":"Shiraishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiko","family":"Usui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohide","family":"Sanada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norifumi","family":"Kennoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Okubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Tokuuye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,5,5]]},"reference":[{"key":"key20180107152402_b1-mco-0-0-1241","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1002\/1097-0142(19831015)52:8<1410::AID-CNCR2820520813>3.0.CO;2-3","article-title":"Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma","volume":"52","author":"Isaacson","year":"1983","journal-title":"Cancer"},{"key":"key20180107152402_b2-mco-0-0-1241","volume-title":"World Health Organization Classification of Tumors: Pathology and Genetics of Tumorus of Haematopoietic and Lymphoid Tissues","author":"Jaffe","year":"2001"},{"key":"key20180107152402_b3-mco-0-0-1241","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma study group","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"key":"key20180107152402_b4-mco-0-0-1241","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/ajh.24086","article-title":"Non-Hodgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: A longitudinal analysis of the National Cancer Data Base from 1998\u20132011","volume":"90","author":"Al-Hamadani","year":"2015","journal-title":"Am J Hematol"},{"key":"key20180107152402_b5-mco-0-0-1241","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1038\/bjc.2011.450","article-title":"Incidence of haematological malignancy by sub-type: A report from the Haematological Malignancy research network","volume":"105","author":"Smith","year":"2011","journal-title":"Br J Cancer"},{"key":"key20180107152402_b6-mco-0-0-1241","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/jnci\/djh102","article-title":"Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas","volume":"96","author":"Ferreri","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"key20180107152402_b7-mco-0-0-1241","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/S0360-3016(03)00767-3","article-title":"Ocular adnexal lymphoma: Clinical behavior of distinct World Health Organization classification subtypes","volume":"57","author":"Fung","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20180107152402_b8-mco-0-0-1241","doi-asserted-by":"crossref","first-page":"344","DOI":"10.5301\/ejo.5000224","article-title":"Ocular adnexal lymphoma staging and treatment: American joint committee on cancer versus Ann Arbor","volume":"23","author":"Graue","year":"2013","journal-title":"Eur J Ophthalmol"},{"key":"key20180107152402_b9-mco-0-0-1241","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1136\/bjo.84.8.907","article-title":"Histological features of ocular adnexal lymphoma (REAL classification) and their association with patient morbidity and survival","volume":"84","author":"Jenkins","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"key20180107152402_b10-mco-0-0-1241","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.3109\/10428194.2014.979415","article-title":"Long-term outcomes and patterns of failure in orbital lymphoma treated with primary radiotherapy","volume":"56","author":"Parikh","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"key20180107152402_b11-mco-0-0-1241","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.ijrobp.2005.03.005","article-title":"Radiation therapy for orbital lymphoma","volume":"63","author":"Zhou","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20180107152402_b12-mco-0-0-1241","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ijrobp.2013.11.235","article-title":"Localized ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiation therapy: A long-term outcome in 86 patients with 104 treated eyes","volume":"88","author":"Harada","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20180107152402_b13-mco-0-0-1241","doi-asserted-by":"crossref","first-page":"e659","DOI":"10.1016\/j.ijrobp.2011.03.050","article-title":"Localized orbital mucosa-associated lymphoma tissue lymphoma managed with primary radiation therapy: Efficacy and toxicity","volume":"81","author":"Goda","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20180107152402_b14-mco-0-0-1241","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1365-2141.2010.08429.x","article-title":"Primary ocular adnexal mucosa-associated lymphoid tissue lymphoma (MALT): Single institution experience in a large cohort of patients","volume":"152","author":"Bayraktar","year":"2011","journal-title":"Br J Haematol"},{"key":"key20180107152402_b15-mco-0-0-1241","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3109\/10428194.2012.717279","article-title":"Efficacy of low dose radiotherapy for primary orbital marginal zone lymphoma","volume":"54","author":"Tran","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"key20180107152402_b16-mco-0-0-1241","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ijrobp.2005.11.035","article-title":"Orbital marginal zone B-cell lymphoma of MALT: Radiotherapy results and clinical behavior","volume":"65","author":"Suh","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20180107152402_b17-mco-0-0-1241","first-page":"1860","article-title":"Report of the committee on hodgkin's disease staging classification","volume":"31","author":"Carbone","year":"1971","journal-title":"Cancer Res"},{"key":"key20180107152402_b18-mco-0-0-1241","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1182\/blood-2008-12-195453","article-title":"Extranodal marginal zone lymphoma of the ocular adnexa","volume":"114","author":"Stefanovic","year":"2009","journal-title":"Blood"},{"key":"key20180107152402_b19-mco-0-0-1241","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijrobp.2015.01.009","article-title":"Modern radiation therapy for extranodal lymphomas: Field and dose guidelines from the international lymphoma radiation oncology group","volume":"92","author":"Yahalom","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20180107152402_b20-mco-0-0-1241","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1259\/0007-1285-62-740-679","article-title":"The linear-quadratic formula and progress in fractionated radiotherapy","volume":"62","author":"Fowler","year":"1989","journal-title":"Br J Radiol"},{"key":"key20180107152402_b21-mco-0-0-1241","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.ijrobp.2013.04.035","article-title":"Low-dose radiation therapy (2 Gy \u00d7 2) in the treatment of orbital lymphoma","volume":"86","author":"Fasola","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20180107152402_b22-mco-0-0-1241","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1470-2045(14)70036-1","article-title":"4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): A randomised phase 3 non-inferiority trial","volume":"15","author":"Hoskin","year":"2014","journal-title":"Lancet Oncol"},{"key":"key20180107152402_b23-mco-0-0-1241","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ijrobp.2004.03.039","article-title":"Orbital lymphoma: Is it necessary to treat the entire orbit?","volume":"60","author":"Pfeffer","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20180107152402_b24-mco-0-0-1241","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.ijrobp.2011.12.097","article-title":"Risk of radiation retinopathy in patients with orbital and ocular lymphoma","volume":"84","author":"Kaushik","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20180107152402_b25-mco-0-0-1241","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1182\/blood-2013-02-486522","article-title":"Antibiotic therapy in nongastrointestinal MALT lymphoma: A review of the literature","volume":"122","author":"Kiesewetter","year":"2013","journal-title":"Blood"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T00:47:23Z","timestamp":1602031643000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mco.2017.1241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,5]]},"references-count":25,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,5,5]]},"published-print":{"date-parts":[[2017,6]]}},"alternative-id":["10.3892\/mco.2017.1241"],"URL":"https:\/\/doi.org\/10.3892\/mco.2017.1241","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,5]]}}}